Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Sourcing the immune system to induce immunogenic cell death in Kras-colorectal cancer cells.

Cirone M, Lotti LV, Granato M, Renzo LD, Biunno I, Cattaneo M, Verginelli F, Vespa S, Davies D, Wells V, Mariani-Costantini R, Mallucci L.

Br J Cancer. 2019 Sep 27. doi: 10.1038/s41416-019-0561-z. [Epub ahead of print]

PMID:
31558803
2.

Tympanojugular Paragangliomas: Surgical Management and Clinicopathological Features.

Prasad SC, Paties CT, Schiavi F, Esposito DL, Lotti LV, Mariani-Costantini R, Sanna M.

In: Mariani-Costantini R, editor. Paraganglioma: A Multidisciplinary Approach [Internet]. Brisbane (AU): Codon Publications; 2019 Jul 2. Chapter 6.

3.

A Developmental Perspective on Paragangliar Tumorigenesis.

Lotti LV, Vespa S, Pantalone MR, Perconti S, Esposito DL, Visone R, Veronese A, Paties CT, Sanna M, Verginelli F, Nauclér CS, Mariani-Costantini R.

Cancers (Basel). 2019 Feb 26;11(3). pii: E273. doi: 10.3390/cancers11030273. Review.

4.

Correction to: Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.

Verginelli F, Perconti S, Vespa S, Schiavi F, Prasad SC, Lanuti P, Cama A, Tramontana L, Esposito DL, Guarnieri S, Sheu A, Pantalone MR, Florio R, Morgano A, Rossi C, Bologna G, Marchisio M, D'Argenio A, Taschin E, Visone R, Opocher G, Veronese A, Paties CT, Rajasekhar VK, Söderberg-Nauclér C, Sanna M, Lotti LV, Mariani-Costantini R.

Acta Neuropathol. 2018 May;135(5):799. doi: 10.1007/s00401-018-1811-5.

PMID:
29392445
5.

Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.

Verginelli F, Perconti S, Vespa S, Schiavi F, Prasad SC, Lanuti P, Cama A, Tramontana L, Esposito DL, Guarnieri S, Sheu A, Pantalone MR, Florio R, Morgano A, Rossi C, Bologna G, Marchisio M, D'Argenio A, Taschin E, Visone R, Opocher G, Veronese A, Paties CT, Rajasekhar VK, Söderberg-Nauclér C, Sanna M, Lotti LV, Mariani-Costantini R.

Acta Neuropathol. 2018 May;135(5):779-798. doi: 10.1007/s00401-017-1799-2. Epub 2018 Jan 5. Erratum in: Acta Neuropathol. 2018 Feb 1;:.

6.

Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment.

Massimi I, Lotti LV, Temperilli F, Mancone M, Sardella G, Calcagno S, Turriziani O, Frati L, Pulcinelli FM.

Thromb Haemost. 2016 Nov 30;116(6):1100-1110. Epub 2016 Sep 29.

PMID:
27683757
7.

Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells.

Nicolazzo C, Massimi I, Lotti LV, Vespa S, Raimondi C, Pulcinelli FM, Gradilone A, Gazzaniga P.

Chin J Cancer Res. 2015 Oct;27(5):491-6. doi: 10.3978/j.issn.1000-9604.2015.04.09.

8.

Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells.

Granato M, Chiozzi B, Filardi MR, Lotti LV, Di Renzo L, Faggioni A, Cirone M.

Cancer Lett. 2015 Oct 1;366(2):191-7. doi: 10.1016/j.canlet.2015.07.006. Epub 2015 Jul 13.

PMID:
26184999
9.

Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication.

Granato M, Santarelli R, Farina A, Gonnella R, Lotti LV, Faggioni A, Cirone M.

J Virol. 2014 Nov;88(21):12715-26. doi: 10.1128/JVI.02199-14. Epub 2014 Aug 20.

10.

Palladium nanoparticles induce disturbances in cell cycle entry and progression of peripheral blood mononuclear cells: paramount role of ions.

Petrarca C, Clemente E, Di Giampaolo L, Mariani-Costantini R, Leopold K, Schindl R, Lotti LV, Mangifesta R, Sabbioni E, Niu Q, Bernardini G, Di Gioacchino M.

J Immunol Res. 2014;2014:295092. doi: 10.1155/2014/295092. Epub 2014 Jul 3.

11.

Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets.

Massimi I, Guerriero R, Lotti LV, Lulli V, Borgognone A, Romani F, Barillà F, Gaudio C, Gabbianelli M, Frati L, Pulcinelli FM.

Br J Clin Pharmacol. 2014 Dec;78(6):1343-53. doi: 10.1111/bcp.12432.

12.

JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells.

Granato M, Santarelli R, Lotti LV, Di Renzo L, Gonnella R, Garufi A, Trivedi P, Frati L, D'Orazi G, Faggioni A, Cirone M.

PLoS One. 2013 Sep 26;8(9):e75965. doi: 10.1371/journal.pone.0075965. eCollection 2013.

13.

Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.

Cama A, Verginelli F, Lotti LV, Napolitano F, Morgano A, D'Orazio A, Vacca M, Perconti S, Pepe F, Romani F, Vitullo F, di Lella F, Visone R, Mannelli M, Neumann HP, Raiconi G, Paties C, Moschetta A, Tagliaferri R, Veronese A, Sanna M, Mariani-Costantini R.

Acta Neuropathol. 2013 Oct;126(4):575-94. doi: 10.1007/s00401-013-1165-y. Epub 2013 Aug 18.

14.

HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma.

Granato M, Lacconi V, Peddis M, Lotti LV, Di Renzo L, Gonnella R, Santarelli R, Trivedi P, Frati L, D'Orazi G, Faggioni A, Cirone M.

Cell Death Dis. 2013 Jul 18;4:e730. doi: 10.1038/cddis.2013.263. Erratum in: Cell Death Dis. 2014;5:e2154. Renzo, L D [corrected to Di Renzo, L].

15.

Synthesis and cytotoxicity of novel (thiazol-2-yl)hydrazine derivatives as promising anti-Candida agents.

Carradori S, Secci D, Bolasco A, Rivanera D, Mari E, Zicari A, Lotti LV, Bizzarri B.

Eur J Med Chem. 2013 Jul;65:102-11. doi: 10.1016/j.ejmech.2013.04.042. Epub 2013 May 1.

PMID:
23702472
16.

JNK2 is activated during ER stress and promotes cell survival.

Raciti M, Lotti LV, Valia S, Pulcinelli FM, Di Renzo L.

Cell Death Dis. 2012 Nov 22;3:e429. doi: 10.1038/cddis.2012.167.

17.

Activation of dendritic cells by tumor cell death.

Cirone M, Di Renzo L, Lotti LV, Conte V, Trivedi P, Santarelli R, Gonnella R, Frati L, Faggioni A.

Oncoimmunology. 2012 Oct 1;1(7):1218-1219.

18.

Killing of Kras-mutant colon cancer cells via Rac-independent actin remodeling by the βGBP cytokine, a physiological PI3K inhibitor therapeutically effective in vivo.

Mallucci L, Shi DY, Davies D, Jordan P, Nicol A, Lotti L, Mariani-Costantini R, Verginelli F, Wells V, Zicha D.

Mol Cancer Ther. 2012 Sep;11(9):1884-93. doi: 10.1158/1535-7163.MCT-11-1041-T. Epub 2012 Jul 2.

19.

The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer.

Esposito DL, Aru F, Lattanzio R, Morgano A, Abbondanza M, Malekzadeh R, Bishehsari F, Valanzano R, Russo A, Piantelli M, Moschetta A, Lotti LV, Mariani-Costantini R.

PLoS One. 2012;7(4):e36190. doi: 10.1371/journal.pone.0036190. Epub 2012 Apr 27.

20.

Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91.

Cirone M, Di Renzo L, Lotti LV, Conte V, Trivedi P, Santarelli R, Gonnella R, Frati L, Faggioni A.

PLoS One. 2012;7(3):e31732. doi: 10.1371/journal.pone.0031732. Epub 2012 Mar 7.

21.

Allergic and photoallergic conditions from unusual chlorpromazine exposure: report of three cases.

Giomi B, Difonzo EM, Lotti L, Massi D, Francalanci S.

Int J Dermatol. 2011 Oct;50(10):1276-8. doi: 10.1111/j.1365-4632.2010.04613.x. No abstract available.

PMID:
21950296
22.

Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of palladium-sensitized women.

Reale M, Vianale G, Lotti LV, Mariani-Costantini R, Perconti S, Cristaudo A, Leopold K, Antonucci A, Di Giampaolo L, Iavicoli I, Di Gioacchino M, Boscolo P.

J Occup Environ Med. 2011 Sep;53(9):1054-60. doi: 10.1097/JOM.0b013e318228115e.

PMID:
21866053
23.

Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.

Mattiello T, Guerriero R, Lotti LV, Trifirò E, Felli MP, Barbarulo A, Pucci B, Gazzaniga P, Gaudio C, Frati L, Pulcinelli FM.

J Am Coll Cardiol. 2011 Aug 9;58(7):752-61. doi: 10.1016/j.jacc.2011.03.049. Erratum in: J Am Coll Cardiol. 2011 Oct 18;58(17):1832.

24.

Madurella mycetomatis mycetoma treated successfully with oral posaconazole.

Difonzo EM, Massi D, Vanzi L, Lotti L, Agnoletti AF, Baldinotti V.

J Chemother. 2011 Aug;23(4):243-4. No abstract available.

PMID:
21803706
25.

Secretion of novel SEL1L endogenous variants is promoted by ER stress/UPR via endosomes and shed vesicles in human cancer cells.

Cattaneo M, Lotti LV, Martino S, Alessio M, Conti A, Bachi A, Mariani-Costantini R, Biunno I.

PLoS One. 2011 Feb 17;6(2):e17206. doi: 10.1371/journal.pone.0017206.

26.

One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis.

Di Paolo D, Lenci I, Cerocchi C, Tariciotti L, Monaco A, Brega A, Lotti L, Tisone G, Angelico M.

Transpl Int. 2010 Nov;23(11):1105-12. doi: 10.1111/j.1432-2277.2010.01104.x. Epub 2010 Aug 19.

27.

Mesotherapy and cutaneous Mycobacterium fortuitum infection.

Difonzo EM, Campanile GL, Vanzi L, Lotti L.

Int J Dermatol. 2009 Jun;48(6):645-7. doi: 10.1111/j.1365-4632.2009.03487.x.

PMID:
19538379
28.

Functional characterization of two secreted SEL1L isoforms capable of exporting unassembled substrate.

Cattaneo M, Lotti LV, Martino S, Cardano M, Orlandi R, Mariani-Costantini R, Biunno I.

J Biol Chem. 2009 Apr 24;284(17):11405-15. doi: 10.1074/jbc.M805408200. Epub 2009 Feb 9.

29.

Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy.

Gradilone A, Pulcinelli FM, Lotti LV, Trifirò E, Martino S, Gandini O, Gianni W, Frati L, Aglianò AM, Gazzaniga P.

Curr Cancer Drug Targets. 2008 Aug;8(5):414-20.

PMID:
18690847
30.

Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study.

Di Fonzo EM, Martini P, Mazzatenta C, Lotti L, Alvino S.

Mycoses. 2008 Nov;51(6):532-5. doi: 10.1111/j.1439-0507.2008.01508.x. Epub 2008 Apr 16.

PMID:
18422916
31.

Autophagy in hematopoietic stem/progenitor cells exposed to heavy metals: Biological implications and toxicological relevance.

Di Gioacchino M, Petrarca C, Perrone A, Martino S, Esposito DL, Lotti LV, Mariani-Costantini R.

Autophagy. 2008 May;4(4):537-9. Epub 2008 Mar 26.

PMID:
18398291
32.

SEL1L and HRD1 are involved in the degradation of unassembled secretory Ig-mu chains.

Cattaneo M, Otsu M, Fagioli C, Martino S, Lotti LV, Sitia R, Biunno I.

J Cell Physiol. 2008 Jun;215(3):794-802. doi: 10.1002/jcp.21364.

PMID:
18314878
33.

Autophagy as an ultrastructural marker of heavy metal toxicity in human cord blood hematopoietic stem cells.

Di Gioacchino M, Petrarca C, Perrone A, Farina M, Sabbioni E, Hartung T, Martino S, Esposito DL, Lotti LV, Mariani-Costantini R.

Sci Total Environ. 2008 Mar 15;392(1):50-8. doi: 10.1016/j.scitotenv.2007.11.009. Epub 2007 Dec 31.

PMID:
18166216
34.

Melanosome transfer promoted by keratinocyte growth factor in light and dark skin-derived keratinocytes.

Cardinali G, Bolasco G, Aspite N, Lucania G, Lotti LV, Torrisi MR, Picardo M.

J Invest Dermatol. 2008 Mar;128(3):558-67. Epub 2007 Sep 20.

35.

Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.

Gradilone A, Pulcinelli FM, Lotti LV, Martino S, Mattiello T, Frati L, Aglianò AM, Gazzaniga P.

J Clin Oncol. 2007 Sep 20;25(27):4318-20; author reply 4320. No abstract available.

PMID:
17878487
36.

AKT and MAPK signaling in KGF-treated and UVB-exposed human epidermal cells.

Lotti LV, Rotolo S, Francescangeli F, Frati L, Torrisi MR, Marchese C.

J Cell Physiol. 2007 Sep;212(3):633-42.

PMID:
17458890
37.

Tuberculous gumma in a patient with cervical lymphadenitis.

Difonzo EM, Lotti L, Salvini C, Sestini S, Fabroni C.

Int J Dermatol. 2006 Dec;45(12):1467-8. No abstract available.

PMID:
17184269
38.

The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion.

Semino C, Ceccarelli J, Lotti LV, Torrisi MR, Angelini G, Rubartelli A.

J Leukoc Biol. 2007 Jan;81(1):92-9. Epub 2006 Sep 22.

PMID:
16997859
39.

Keratinocyte growth factor promotes melanosome transfer to keratinocytes.

Cardinali G, Ceccarelli S, Kovacs D, Aspite N, Lotti LV, Torrisi MR, Picardo M.

J Invest Dermatol. 2005 Dec;125(6):1190-9.

40.

Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents.

Riondino S, Lotti LV, Cutini L, Pulcinelli FM.

J Biol Chem. 2005 Feb 25;280(8):6504-10. Epub 2004 Dec 14.

41.

Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes.

Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, Rubartelli A.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9745-50. Epub 2004 Jun 10.

42.
43.

Subcellular localization of the BRCA1 gene product in mitotic cells.

Lotti LV, Ottini L, D'Amico C, Gradini R, Cama A, Belleudi F, Frati L, Torrisi MR, Mariani-Costantini R.

Genes Chromosomes Cancer. 2002 Nov;35(3):193-203.

PMID:
12353262
44.

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway.

Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A.

EMBO Rep. 2002 Oct;3(10):995-1001. Epub 2002 Sep 13.

45.

CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D.

Gardella S, Andrei C, Lotti LV, Poggi A, Torrisi MR, Zocchi MR, Rubartelli A.

Blood. 2001 Oct 1;98(7):2152-9.

PMID:
11568002
46.
48.

Intracellular transport and maturation pathway of human herpesvirus 6.

Torrisi MR, Gentile M, Cardinali G, Cirone M, Zompetta C, Lotti LV, Frati L, Faggioni A.

Virology. 1999 May 10;257(2):460-71.

49.

The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles.

Andrei C, Dazzi C, Lotti L, Torrisi MR, Chimini G, Rubartelli A.

Mol Biol Cell. 1999 May;10(5):1463-75.

50.

Supplemental Content

Support Center